References
- 1. Yazdanpanah L, Shahbazian H, Nazari I, et al. Incidence and Risk Factors of Diabetic Foot Ulcer: A Population-Based Diabetic Foot Cohort (ADFC Study)-Two-Year Follow-Up Study. Int J Endocrinol. 2018; 2018:7631659.10.1155/2018/7631659
- 2. Gershater MA, Löndahl M, Nyberg P, Larsson J, Thörne J, Eneroth M, Apelqvist J. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study.Diabetologia. 2009 Mar;52(3):398-407.10.1007/s00125-008-1226-2
- 3. Zhang P, Lu J1 Jing Y, Tang S, Zhu D, Bi Y Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis Ann Med. 2017 Mar;49(2):106-116.10.1080/07853890.2016.1231932
- 4. Bondor C, Veresiu I, Florea B, Vinik E, Vinik A, Gavan N Epidemiology of Diabetic Foot Ulcers and Amputations in Romania: Results of a Cross-Sectional Quality of Life Questionnaire Based Survey. Journal of Diabetes Research. 2016. 10.1155/2016/5439521.10.1155/2016/5439521
- 5. Zochodne DW Diabetic polyneuropathy: an update Curr Opin Neurol. 2008 Oct;21(5):527-33.10.1097/WCO.0b013e32830b84cb
- 6. Paraskevas KI, Baker DM, Pompella A, Mikhailidis DP. Does diabetes mellitus play a role in restenosis and patency rates following lower extremity peripheral arterial revascularization? A critical overview Ann Vasc Surg. 2008 May-Jun;22(3):481-91.10.1016/j.avsg.2007.12.012
- 7. Clayton W, Elasy T, A Review of the Pathophysiology, Classification, and Treatment of Foot Ulcers in Diabetic Patients Clinical Diabetes. 2009 Apr;27(2):52-58.10.2337/diaclin.27.2.52
- 8. Noor S, Zubair M, Ahmad J. Diabetic foot ulcer--A review on pathophysiology, classification and microbial etiology.Diabetes Metab Syndr. 2015 Jul-Sep;9(3):192-9.10.1016/j.dsx.2015.04.007
- 9. Durgia H, Sahoo J, Kamalanathan S, Palui R, Sridharan K, Raj H. Role of bisphosphonates in the management of acute Charcot foot. World J Diabetes. 2018;9(7):115-126.10.4239/wjd.v9.i7.115
- 10. Chisholm KA, Gilchrist JM The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011 Sep;13(1):1-13.10.1097/CND.0b013e3181c6f55b
- 11. Ramanujam CL, Zgonis T. The Diabetic Charcot Foot from 1936 to 2016: Eighty Years Later and Still Growing. Clin Podiatr Med Surg. 2017 Jan;34(1):1-8.10.1016/j.cpm.2016.07.001
- 12. Zhao HM, Diao JY, Liang XJ, Zhang F, Hao DJ. Pathogenesis and potential relative risk factors of diabetic neuropathic osteoarthropathy. J Orthop Surg Res. 2017;12(1):142. Published 2017 Oct 2.10.1186/s13018-017-0634-8
- 13. Kaynak G, Birsel O, Güven MF, Oğüt T. An overview of the Charcot foot pathophysiology. Diabet Foot Ankle. 2013;4:10.3402/dfa.v4i0.21117. Published 2013 Aug 2.10.3402/dfa.v4i0.21117
- 14. Kucera T, Shaikh HH, Sponer P. Charcot Neuropathic Arthropathy of the Foot: A Literature Review and Single-Center Experience. J Diabetes Res. 2016;2016:3207043.10.1155/2016/3207043
- 15. Lee L, Blume PA, Sumpio B. Charcot joint disease in diabetes mellitus Ann Vasc Surg. 2003 Sep;17(5):571-80.10.1007/s10016-003-0039-5
- 16. Jeffcoate WJ, Game F, Cavanagh PR. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005 Dec 10;366(9502):2058-61.10.1016/S0140-6736(05)67029-8
- 17. Karabiber A, Kaynak G, Oğüt T. Conservative and surgical treatment of the chronic Charcot foot and ankle Diabet Foot Ankle. 2013 Aug 2;410.3402/dfa.v4i0.21177
- 18. Hanft JR, Goggin JP, Landsman A, Surprenant M. The role of combined magnetic field bone growth stimulation as an adjunct in the treatment of neuroarthropathy/Charcot joint: an expanded pilot study. J Foot Ankle Surg. 1998 Nov-Dec;37(6):510-5; discussion 550.10.1016/S1067-2516(98)80028-8
- 19. Madan SS, Pai DR. Charcot neuroarthropathy of the foot and ankle. Orthop Surg. 2013;5(2):86-93.10.1111/os.12032
- 20. Catanzariti AR, Mendicino R, Haverstock B. Ostectomy for diabetic neuroarthropathy involving the midfoot. J Foot Ankle Surg. 2000 Sep-Oct;39(5):291-300.10.1016/S1067-2516(00)80045-9